News
- Author:
- Lucy Hicks
Publish date: August 31, 2023
Rheumatologists can save health systems more than $2,700 per patient per year, and each can generate $3.5 million in annual billings, according to ...
News
- Author:
- Lucy Hicks
Publish date: August 30, 2023
Research-associated payments dipped by 24% from 2014 to 2022, new data suggest.
News
- Author:
- Lucy Hicks
Publish date: August 30, 2023
Canakinumab is the first biologic in the U.S. approved for treating gout flares.
News
- Author:
- Lucy Hicks
Publish date: August 30, 2023
“Guidance was needed for which tests to use for screening and monitoring this particular disease,” said lead author Sindhu R. Johnson, MD, PhD. The...
News
- Author:
- Lucy Hicks
Publish date: August 17, 2023
The FDA issued the warning letter on Aug. 4 and published it on Aug. 15.
News
- Author:
- Lucy Hicks
Publish date: August 8, 2023
If validated as a biomarker, antigephyrin autoantibodies could help identify patients at higher risk for GI symptoms like constipation.
News
- Author:
- Lucy Hicks
Publish date: August 7, 2023
A daily prednisolone dose of less than 5 mg was not associated with increased cardiovascular risk, whereas a dose of 5 mg or more doubled the risk ...
News
- Author:
- Lucy Hicks
Publish date: August 4, 2023
Nearly 90% of authors with potential conflicts of interest either underreported or did not report disclosures.
News
- Author:
- Lucy Hicks
Publish date: August 4, 2023
The autoantibodies anti-POLR3 and monospecific anti-Ro52 were associated with increased cancer risk, while anti-centromere and anti-U1RNP were tied...
News
- Author:
- Lucy Hicks
Publish date: August 2, 2023
The two tool scores could help determine who can be managed in primary care and who may qualify for intervention studies.
News
- Author:
- Lucy Hicks
Publish date: August 2, 2023
The U.S. News & World Report’s rheumatology rankings were determined from expert opinion surveys over the past 3 years.
News
- Author:
- Lucy Hicks
Publish date: July 28, 2023
A new prognostic model accurately predicts a patient’s risk of experiencing methotrexate toxicity, but more research is needed before clinical appl...
News
- Author:
- Lucy Hicks
Publish date: July 24, 2023
Experts say that these negative findings do not imply that other vagus nerve stimulation therapies will be unsuccessful.
News
- Author:
- Lucy Hicks
Publish date: July 19, 2023
The launch of eight adalimumab biosimilars so far in 2023 ended Humira’s 20-year monopoly, but it’s not clear yet if these discounted drugs will sa...
News
- Author:
- Lucy Hicks
Publish date: June 28, 2023
Intercept first sought FDA approval for OCA in 2019. The company will discontinue all NASH-related investment.
